Codesign of digital health tools for suicide prevention: A scoping

Abstract


71
Suicide affects more than 700,000 globally each year [1]  Patient* OR student* OR "internet user*" OR Adult* OR pupil* OR soldier* OR "experts by experience" OR "service user*" Concept Suicide intervention Suicide reduction Digital intervention Suicide prevention Softwar* OR app* OR tool* OR technolog* OR digital* AND suicide* OR "suicide prevent*" OR "suicide reduc*" OR "suicide intervent*" OR MH* OR "internet based" OR "web based" OR "mobile based" is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint 7 135 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint From the-1640 articles uploaded into Covidence, the title and abstracts were screened by DW and 143 WAB and MN resolved any conflicts. Full-text articles were discussed among the research team to 144 ensure moderation of the process particularly with experts-by-experience. Once the inclusion and 145 exclusion criteria were applied, we removed 1588 studies, leaving at total of 61 records (n=52 146 published articles, n=9 records from grey literature).

147
Stage Four: Charting the data 148 All included data were first extracted from full-text articles and read and excerpts that were relevant 149 to the research question were highlighted. Data from grey literature sources were also included in the 150 data extraction table and included digital interventions predominantly from non-government . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023.  Interventions limited within the literature, qualitative data excluded. Acceptability based upon participant reported experiences of using the intervention, specifically how helpful or useful the intervention was, or the perceived likelihood of using it again in the future. Feasibility based upon intervention engagement or usage rates (e.g., number of times accessing a mobile phone app during the study period). Suicidal ideation was also included as a secondary outcome.

167
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Study characteristics of the included studies
170 Table 3 provides an overview of the study characteristics. There were several study types from the 52 171 published articles including four randomized control trials [17][18][19][20] . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023.   Table 4 provides an overview of the five themes that emerged from the 52 peer reviewed articles and 192 9 items from grey literature. We found the first theme of acceptability by users was prominent from , 50] and one study specifically recommended targeting adolescents whom the authors argued have 211 a greater acceptance of technologies [3]. Interestingly, given that the recommendations from these 212 articles were to include experts-by-experience within health research, we found it surprising that such 213 recommendations were identified and not followed through by the authors themselves. We found 214 one exception where the Samaritans' website was reviewed from 2017-2019 [65]. The review . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint consultation with people with lived-experience a new website (StayingSafe) included strategies for   217 developing a safety plan and lived-experience video footage. The review found that it was important 218 to continue evaluating developments and identify models of effective help provision. In addition, it 219 was noted that users should be involved not only in such evaluation, but also as co-producers of new 220 online materials and approaches.

262
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint Majority of research in developed countries [32] More affordable and reduced stigma . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted April 12, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 12, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint The online treatment of suicidal ideation: A randomised controlled trial of an unguided web-based . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 12, 2023. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint https://doi.org/10.2196/jmir.2973 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 12, 2023. ; https://doi.org/10.1101/2023.04.11.23288415 doi: medRxiv preprint